Pfizer Inc (PFE)

Industry Drug Manufacturers - General

This stock can be held in an Investment ISA and an Investment Account

Sell

$23.52

Buy

$23.53

arrow-up$0.04 (+0.17%)

Prices updated at 30 May 2025, 23:46 EDT

Prices minimum 15 mins delay

Prices in USD

Pfizer Inc is a biopharmaceutical company that discovers, develops, manufactures, and markets healthcare products including medicines, and vaccines as well as many of the consumer healthcare products.

S&P 500

-0.01%

NYSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Drug Manufacturers - General

Chairman

Dr. Albert Bourla, D.V.M.,PhD

CEO

Dr. Albert Bourla, D.V.M.,PhD

Most recent earnings

31 Dec 2024

Fiscal year end

31 Dec 2024

Employees

81,000

Head office

66 Hudson Boulevard East

New York

United States

10001-2192

+1 212 733-2323

IR@pfizer.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. David M. Denton Chief Financial Officer and Executive Vice President	1.35m
Ms. Lidia L. Fonseca Executive Vice President, Chief Digital and Technology Officer	-
Ms. Sally Susman Chief Corporate Affairs Officer and Executive Vice President	-
Mr. Ronald E. Blaylock Independent Director	0.16m
Mr. Shantanu Narayen Lead Independent Director	0.21m
Ms. Suzanne Nora Johnson Independent Director	0.19m
Dr. Scott Gottlieb,M.D. Independent Director	0.19m
Mr. James Robert Quincey Independent Director	0.16m
Dr. Susan J. Hockfield, PhD Independent Director	0.16m
Dr. Susan D. Desmond-Hellmann, M.D.,M.P.H. Independent Director	0.16m
Mr. Douglas M. Lankler Chief Legal Officer and Executive Vice President	-
Mr. James C. Smith Independent Director	0.19m
Dr. Albert Bourla, D.V.M.,PhD Chairman of the Board and Chief Executive Officer	1.80m
Mr. Joseph J. Echevarria Independent Director	0.19m
Ms. Margaret M. Madden Senior Vice President, Corporate Secretary and Chief Governance Counsel	-
Mr. Cyrus Taraporevala Independent Director	0.08m
Dr. Dan R. Littman, M.D.,PhD Independent Director	0.16m
Ms. Jennifer B. Damico Principal Accounting Officer, Senior Vice President and Controller	-
Ms. Payal Sahni Chief People Experience Officer and Executive Vice President	-
Mr. Aamir Malik Chief U.S. Commercial Officer and Executive Vice President	1.34m
Mr. Michael McDermott Executive Vice President, Chief Global Supply and Quality Officer	-
Dr. Chris Boshoff, M.D.,PhD Chief Scientific Officer and President, Research and Development	1.20m
Mr. Alexandre de Germay Chief International Commercial Officer and Executive Vice President	-
Dr. Andrew Baum, M.D. Executive Vice President, Chief Strategy and Innovation Officer	-
Mr. Mortimer J. Buckley Independent Director	0.03m

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
Vanguard Group Inc	523,165,127
BlackRock Inc	474,167,592
State Street Corp	296,970,528
Vanguard Investments Australia Ltd	182,559,049
Vanguard Total Stock Market Index Fund	181,790,216

Director dealings

Date chevron-l-regular chevron-r-regular	Action
31 Dec 2024	-
31 Dec 2024	-
31 Dec 2024	-
31 Dec 2024	-
31 Dec 2024	-
31 Dec 2024	-
31 Dec 2024	-
13 Dec 2024	-
13 Dec 2024	-
29 Nov 2024	-
29 Nov 2024	-
15 Nov 2024	-
15 Nov 2024	-
31 Oct 2024	-
31 Oct 2024	-
30 Oct 2024	-
15 Oct 2024	-
15 Oct 2024	-
10 Oct 2024	-
10 Oct 2024	-

Please note that past performance is not a reliable indicator of future returns.

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.